P

Inventor

KULKARNI SANTOSH S

IN42 patents
⚠️ This page may combine multiple inventors who share the name “KULKARNI SANTOSH S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ALBIREO AB

21 patents
US11572350B1Feb 7, 2023

Benzothia(di)azepine compounds and their use as bile acid modulators

ALBIREO AB17 citations95
US11225466B2Jan 18, 2022

Benzothiadiazepine compounds and their use as bile acid modulators

ALBIREO AB23 citations95
US11267794B2Mar 8, 2022

Benzothia(di)azepine compounds and their use as bile acid modulators

ALBIREO AB21 citations94
US11180465B2Nov 23, 2021

Benzothia(di)azepine compounds and their use as bile acid modulators

ALBIREO AB25 citations94
US11111224B2Sep 7, 2021

Benzothia(di)azepine compounds and their use as bile acid modulators

ALBIREO AB30 citations94
US11014898B1May 25, 2021

Benzothiazepine compounds and their use as bile acid modulators

ALBIREO AB30 citations94
US10975045B2Apr 13, 2021

Benzothiazepine compounds and their use as bile acid modulators

ALBIREO AB23 citations94
US10941127B2Mar 9, 2021

Benzothiadiazepine compounds and their use as bile acid modulators

ALBIREO AB28 citations94
US10793534B2Oct 6, 2020

Benzothia(di)azepine compounds and their use as bile acid modulators

ALBIREO AB21 citations94
US11891368B2Feb 6, 2024

Benzothia(di)azepine compounds and their use as bile acid modulators

ALBIREO AB10 citations86
US11708340B2Jul 25, 2023

Benzothia(di)azepine compounds and their use as bile acid modulators

ALBIREO AB12 citations86
US11377429B2Jul 5, 2022

Benzothia(di)azepine compounds and their use as bile acid modulators

ALBIREO AB13 citations86
US11773071B2Oct 3, 2023

Benzothiazepine compounds and their use as bile acid modulators

ALBIREO AB14 citations85
US11603359B2Mar 14, 2023

Benzothiadiazepine compounds and their use as bile acid modulators

ALBIREO AB11 citations85
US11306064B2Apr 19, 2022

Benzothia(di)azepine compounds and their use as bile acid modulators

ALBIREO AB17 citations85
US12365658B2Jul 22, 2025

Benzothia(di)azepine compounds and their use as bile acid modulators

ALBIREO AB2 citations75
US12202809B2Jan 21, 2025

Benzothia(di)azepine compounds and their use as bile acid modulators

ALBIREO AB4 citations75
US12134606B2Nov 5, 2024

Benzothia(di)azepine compounds and their use as bile acid modulators

ALBIREO AB5 citations75
US12060338B2Aug 13, 2024

Benzothia(di)azepine compounds and their use as bile acid modulators

ALBIREO AB5 citations75
US12024495B2Jul 2, 2024

Benzothiazepine compounds and their use as bile acid modulators

ALBIREO AB5 citations75
US12187690B2Jan 7, 2025

Benzothiadiazepine compounds and their use as bile acid modulators

ALBIREO AB4 citations74

ASCENEURON SA

19 patents
US10336775B2Jul 2, 2019

Glycosidase inhibitors

ASCENEURON SA15 citations94
US10696668B2Jun 30, 2020

Acid addition salts of piperazine derivatives

ASCENEURON SA12 citations92
US11261183B2Mar 1, 2022

Sulfoximine glycosidase inhibitors

ASCENEURON SA11 citations85
US11213525B2Jan 4, 2022

Linear glycosidase inhibitors

ASCENEURON SA9 citations85
US11046712B2Jun 29, 2021

Glycosidase inhibitors

ASCENEURON SA11 citations85
US10995090B2May 4, 2021

Substituted dihydrobenzofuran glycosidase inhibitors

ASCENEURON SA11 citations85
US10556902B2Feb 11, 2020

Glycosidase inhibitors

ASCENEURON SA12 citations85
US10344021B2Jul 9, 2019

Process for the separation of enantiomers of piperazine derivatives

ASCENEURON SA15 citations84
US11591327B2Feb 28, 2023

Acid addition salts of piperazine derivatives

ASCENEURON SA6 citations83
US12187741B2Jan 7, 2025

Glycosidase inhibitors

ASCENEURON SA1 citations74
US11612599B2Mar 28, 2023

Glycosidase inhibitors

ASCENEURON SA6 citations74
US11795165B2Oct 24, 2023

Tetrahydro-benzoazepine glycosidase inhibitors

ASCENEURON SA5 citations73
US12016852B2Jun 25, 2024

Pyrrolidine glycosidase inhibitors

ASCENEURON SA4 citations72
US11731972B2Aug 22, 2023

Spiro compounds as glycosidase inhibitors

ASCENEURON SA5 citations72
US12195455B2Jan 14, 2025

Succinate and fumarate acid addition salts of piperazine derivatives

ASCENEURON SA1 citations63
US12157734B2Dec 3, 2024

Sulfoximine glycosidase inhibitors

ASCENEURON SA1 citations62
US12398130B2Aug 26, 2025

Acid addition salts of piperazine derivatives

ASCENEURON SA0 citations60
US11458140B2Oct 4, 2022

Annulated glycosidase inhibitors

ASCENEURON SA0 citations52
US9505769B2Nov 29, 2016

Tetraaza-cyclopenta[a]indenyl derivatives

ASCENEURON SA0 citations36

SYNDAX PHARMACEUTICALS INC

1 patent

ASTELLAS ENG SMALL MOLECULES US INCORPORATED

1 patent